{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.glucoxbiotech.com/#organization",
      "name": "Glucox Biotech",
      "url": "https://www.glucoxbiotech.com/",
      "description": "Revolutionizing Metabolic Disease Treatment We envision a future where our cutting-edge pipeline, enriched with NADPH oxidase inhibitors, offers transformative solutions for metabolic diseases. Our flagship molecule, the NOX4 inhibitor, stands at the forefront of our research. Explore our mission Our Latest Research in Diabetic Retinopathy In May 2023, the esteemed Diabetes journal, recognized for its […]"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/glucox-biotech#asg",
      "name": "Glucox Biotech ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/glucox-biotech",
      "isPartOf": {
        "@id": "https://www.glucoxbiotech.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}